Picture of Alimera Sciences logo

ALIM — Alimera Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Alimera Sciences Inc reports results for the quarter ended in June - Earnings Summary

* Alimera Sciences Inc  ALIM.OQ  reported a quarterly
adjusted
loss of 45 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 55 cents per share.
    * Revenue fell 32.7% to $14.60 million from a year ago;
analysts
expected $13.14 million. 
    * Alimera Sciences Inc's reported EPS for the quarter was a
loss
of 45 cents​.
    * The mean earnings estimate of analysts had risen by
about 8.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Alimera Sciences Inc shares had fallen by 5.9% this
quarter and
gained 0.4% so far this year.
    * The company reported a quarterly loss of $3.12 million.
    * Wall Street's median 12-month price target for Alimera
Sciences
Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data July 27
at 01:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.55          -0.45          Beat
 Mar. 31 2022      -0.69          -0.85          Missed
 Dec. 31 2021      -0.42          -0.59          Missed
 Sep. 30 2021      -0.52          -0.60          Missed

Recent news on Alimera Sciences

See all news